Global Trust Asset Management’s Quest Diagnostics DGX Stock Holding History

Global Trust Asset Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.6K	Sell	50 -50	-50%	-$9.81K	﹤0.01%	339
2026 Q1	$19.6K	Hold	100	–	–	0.01%	320
2025 Q4	$17.4K	Hold	100	–	–	0.01%	312
2025 Q3	$19.1K	Hold	100	–	–	0.01%	351
2025 Q2	$18K	Hold	100	–	–	0.01%	342
2025 Q1	$16.9K	Sell	100 -228	-70%	-$37.5K	0.01%	321
2024 Q4	$49.5K	Buy	+328	New	+$51K	0.02%	288

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

MGP

M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Global Trust Asset Management's DGX Position: Q2 2026 in Review

Global Trust Asset Management reduced its Quest Diagnostics (DGX) stake by 50% in Q2 2026, selling an estimated $9.81K and leaving 50 shares worth $10.6K. The position accounts for ﹤0.01% of the portfolio, ranked #339.

Global Trust Asset Management first reported a position in DGX in Q4 2024 and has held it in 7 quarters since. The position peaked at $49.5K in Q4 2024. 629 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Global Trust Asset Management held 50 shares of Quest Diagnostics worth $10.6K as of Q2 2026.
Global Trust Asset Management sold 50 Quest Diagnostics shares in Q2 2026, an estimated $9.81K.
Quest Diagnostics made up ﹤0.01% of Global Trust Asset Management's portfolio in Q2 2026, its #339 holding.
Global Trust Asset Management first reported a position in Quest Diagnostics in Q4 2024 and has held it in 7 quarters since.
Global Trust Asset Management's Quest Diagnostics position peaked at $49.5K in Q4 2024.
629 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Global Trust Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.